BCL2 Inhibition: Development and Role of Venetoclax in Cancer

Wissam Assaily, Ph.D.

Abbvie Oncology Team

Tuesday, June 18, 2019 - 4:00pm

MSB 4171

Departmental Seminar

Host: 

Leonardo Salmena

Pharmacology and Toxicology Seminar

Poster: 

Assaily.pdf